Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jean-Louis Alberini

Showing results (31-40 of 49) with videos related to

Pageof 5
Sort By:
Gynecologic Oncology|October 27, 2007
Impact of FDG PET-CT imaging on the decision making in the biologic suspicion of ovarian carcinoma recurrenceMichael Soussan, Myriam Wartski, Pascal Cherel, et al.
European Journal of Nuclear Medicine and Molecular Imaging|September 6, 2007
High and typical 18F-FDG bowel uptake in patients treated with metforminEric Gontier, Emmanuelle Fourme, Myriam Wartski, et al.
Cancer|April 8, 2011
Breast cancer recurrence diagnosis suspected on tumor marker rising: value of whole-body 18FDG-PET/CT imaging and impact on patient managementLaurence Champion, Etienne Brain, Anne-Laure Giraudet, et al.
Scientific Reports|February 12, 2024
Navigating the nuances: comparative analysis and hyperparameter optimisation of neural architectures on contrast-enhanced MRI for liver and liver tumour segmentationFelix Quinton, Benoit Presles, Sarah Leclerc, et al.
Head & Neck|December 17, 2008
Use of single MRI and 18F-FDG PET-CT scans in both diagnosis and radiotherapy treatment planning in patients with head and neck cancer: advantage on target volume and critical organ delineationMiriam Gardner, Philippe Halimi, Danielle Valinta, et al.
International Journal of Cancer|March 26, 2013
miRNA expression profiling of inflammatory breast cancer identifies a 5-miRNA signature predictive of breast tumor aggressivenessFlorence Lerebours, Geraldine Cizeron-Clairac, Aurelie Susini, et al.
European Journal of Nuclear Medicine and Molecular Imaging|December 21, 2011
Assessment of response to endocrine therapy using FDG PET/CT in metastatic breast cancer: a pilot studyNina Mortazavi-Jehanno, Anne-Laure Giraudet, Laurence Champion, et al.
BMJ Open|October 9, 2025
Immediate versus gradual Tocilizu<b>M</b>ab discontinuAtion in G<b>I</b>ant Cell Arteritis: protocol of the multicentre randomised open-label MAGICA trialMaxime Samson, Isabelle Fournel, Abderrahmane Bourredjem, et al.
Molecular Imaging and Biology|December 4, 2015
Multimodal In Vivo Imaging of Tumorigenesis and Response to Chemotherapy in a Transgenic Mouse Model of Mammary CancerJean-Louis Alberini, Raphaël Boisgard, Stéphanie Guillermet, et al.
Journal of Surgical Oncology|April 12, 2011
Diagnostic and therapeutic imaging for cancer: therapeutic considerations and future directionsMack Roach, Jean-Louis Alberini, Alain Paul Pecking, et al.
Pageof 5

Showing results (31-40 of 49) with videos related to

Sort By:
Pageof 5
Gynecologic Oncology|October 27, 2007
Impact of FDG PET-CT imaging on the decision making in the biologic suspicion of ovarian carcinoma recurrenceMichael Soussan, Myriam Wartski, Pascal Cherel, et al.
European Journal of Nuclear Medicine and Molecular Imaging|September 6, 2007
High and typical 18F-FDG bowel uptake in patients treated with metforminEric Gontier, Emmanuelle Fourme, Myriam Wartski, et al.
Cancer|April 8, 2011
Breast cancer recurrence diagnosis suspected on tumor marker rising: value of whole-body 18FDG-PET/CT imaging and impact on patient managementLaurence Champion, Etienne Brain, Anne-Laure Giraudet, et al.
Scientific Reports|February 12, 2024
Navigating the nuances: comparative analysis and hyperparameter optimisation of neural architectures on contrast-enhanced MRI for liver and liver tumour segmentationFelix Quinton, Benoit Presles, Sarah Leclerc, et al.
Head & Neck|December 17, 2008
Use of single MRI and 18F-FDG PET-CT scans in both diagnosis and radiotherapy treatment planning in patients with head and neck cancer: advantage on target volume and critical organ delineationMiriam Gardner, Philippe Halimi, Danielle Valinta, et al.
International Journal of Cancer|March 26, 2013
miRNA expression profiling of inflammatory breast cancer identifies a 5-miRNA signature predictive of breast tumor aggressivenessFlorence Lerebours, Geraldine Cizeron-Clairac, Aurelie Susini, et al.
European Journal of Nuclear Medicine and Molecular Imaging|December 21, 2011
Assessment of response to endocrine therapy using FDG PET/CT in metastatic breast cancer: a pilot studyNina Mortazavi-Jehanno, Anne-Laure Giraudet, Laurence Champion, et al.
BMJ Open|October 9, 2025
Immediate versus gradual Tocilizu<b>M</b>ab discontinuAtion in G<b>I</b>ant Cell Arteritis: protocol of the multicentre randomised open-label MAGICA trialMaxime Samson, Isabelle Fournel, Abderrahmane Bourredjem, et al.
Molecular Imaging and Biology|December 4, 2015
Multimodal In Vivo Imaging of Tumorigenesis and Response to Chemotherapy in a Transgenic Mouse Model of Mammary CancerJean-Louis Alberini, Raphaël Boisgard, Stéphanie Guillermet, et al.
Journal of Surgical Oncology|April 12, 2011
Diagnostic and therapeutic imaging for cancer: therapeutic considerations and future directionsMack Roach, Jean-Louis Alberini, Alain Paul Pecking, et al.
Pageof 5